Loading company…
UltraDx Bio develops ultrasensitive protein assays and diagnostic products for Alzheimer's and other neurodegenerative diseases.
Established in 2022 and based in Shanghai, China, UltraDx Bio develops single-molecule digital protein assays and diagnostic products. It adapted Simoa® technology to develop testing equipment and reagents that detect low levels of Alzheimer's disease biomarkers in peripheral blood. The products are intended to support early diagnosis of Alzheimer's and other neurodegenerative diseases. In November 2023, the company raised approximately CNY 100 million in venture funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in